12 countries in Asia, South America and Europe in search of Iranian vaccine against COVID-19
TEHRAN – Eleven countries in Asia and South America, and one European country have requested the import of an Iranian-made coronavirus vaccine (COVIRAN BAREKAT), said Hassan Jalili, head of vaccine production on Wednesday. .
“However, it is the Ministry of Health that defines the vaccine export policy,” he added, Tasnim reported.
The results of the second phase human trial showed that the vaccine creates 93.5% immunity, he noted.
“We are preparing documents related to the vaccine which will be sent to the World Health Organization once the third clinical phase is completed.”
COVIRAN BAREKAT, the first coronavirus vaccine made by researchers at Imam’s Order Enforcement Headquarters which was unveiled on December 29, 2020, began mass production on March 29.
Meanwhile, a vaccine developed by the Razi Vaccine and Serum Research Institute (Razi Cov Pars) is expected to become the second Iranian-made vaccine to be administered to the population in early August.
Iran has also started human trials of the Fakhra vaccine, the third nationally developed COVID-19 vaccine named after martyr nuclear scientist Mohsen Fakhrizadeh.
“Osvid-19”, the fourth national vaccine produced by Osvah Pharmaceutical Company is also undergoing human trials, which will also be available in early September.